135 related articles for article (PubMed ID: 7965150)
1. Scintigraphic detection of melanoma metastases with a radiolabeled benzamide ([iodine-123]-(S)-IBZM).
Maffioli L; Mascheroni L; Mongioj V; Gasparini M; Baldini MT; Seregni E; Castellani MR; Cascinelli N; Buraggi GL
J Nucl Med; 1994 Nov; 35(11):1741-7. PubMed ID: 7965150
[TBL] [Abstract][Full Text] [Related]
2. Differential accumulation of iodine-123-iodobenzamide in melanotic and amelanotic melanoma metastases in vivo.
Larisch R; Schulte KW; Vosberg H; Ruzicka T; Müller-Gärtner HW
J Nucl Med; 1998 Jun; 39(6):996-1001. PubMed ID: 9627332
[TBL] [Abstract][Full Text] [Related]
3. Limited sensitivity of iodine-123-2-hydroxy-3-iodo-6-methoxy-N-[(1-ethyl-2-pyrrolidinyl)methyl ] benzamide whole-body scintigraphy in patients with malignant melanoma: a comparison with thallium-201 imaging.
Brenner W; Klomp HJ; Bohuslavizki KH; Szonn B; Kampen WU; Henze E
Eur J Nucl Med; 1999 Dec; 26(12):1567-71. PubMed ID: 10638408
[TBL] [Abstract][Full Text] [Related]
4. [Diagnostic value of 123iodine-ibzm scintigraphy for staging of malignant melanomas].
Henker C; Bida B; Markwardt J; Schlag P
Nuklearmedizin; 1997 Jan; 36(1):1-6. PubMed ID: 9082335
[TBL] [Abstract][Full Text] [Related]
5. [123I]IBZM uptake in metastatic melanoma.
Maffioli LS; Mascheroni L; Clemente C; Baldini M; Castellani MR
J Nucl Biol Med (1991); 1993 Mar; 37(1):18-20. PubMed ID: 8329472
[TBL] [Abstract][Full Text] [Related]
6. Unexpected detection of nodular melanoma of the skin on the scalp by I-123 IBZM brain SPECT.
Booij J; Boot E; van Eeden S; van Amelsvoort T
Clin Nucl Med; 2011 Feb; 36(2):148-9. PubMed ID: 21220985
[TBL] [Abstract][Full Text] [Related]
7. Sigma-receptor imaging by means of I123-IDAB scintigraphy: clinical application in melanoma and non-small cell lung cancer.
Everaert H; Flamen P; Franken PR; Verhaeghe W; Bossuyt A
Anticancer Res; 1997; 17(3B):1577-82. PubMed ID: 9179197
[TBL] [Abstract][Full Text] [Related]
8. Comparison of iodine-123-epidepride and iodine-123-IBZM for dopamine D2 receptor imaging.
Leslie WD; Abrams DN; Greenberg CR; Hobson D
J Nucl Med; 1996 Oct; 37(10):1589-91. PubMed ID: 8862288
[TBL] [Abstract][Full Text] [Related]
9. Structure distribution relationship of iodine-123-iodobenzamides as tracers for the detection of melanotic melanoma.
Brandau W; Niehoff T; Pulawski P; Jonas M; Dutschka K; Sciuk J; Coenen HH; Schober O
J Nucl Med; 1996 Nov; 37(11):1865-71. PubMed ID: 8917194
[TBL] [Abstract][Full Text] [Related]
10. [Computed tomography evaluation of metastasis of cutaneous melanoma].
Potente G; Cantisani C; Cantisani V; Bottoni U; Calvieri S; Andreoli GM; Arduini F; Guerrisi R
Radiol Med; 2001 Apr; 101(4):275-80. PubMed ID: 11398059
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of iodine-123-IMBA for melanoma imaging.
Nicholl C; Mohammed A; Hull WE; Bubeck B; Eisenhut M
J Nucl Med; 1997 Jan; 38(1):127-33. PubMed ID: 8998166
[TBL] [Abstract][Full Text] [Related]
12. Visualizing ocular melanoma using iodine-123-N-(2-diethylaminoethyl)4-iodobenzamide SPECT.
Everaert H; Bossuyt A; Flamen P; Mertens J; Franken PR
J Nucl Med; 1997 Jun; 38(6):870-3. PubMed ID: 9189131
[TBL] [Abstract][Full Text] [Related]
13. Detection of melanoma metastases with thallium-201 scintigraphy.
Rettenbacher L; Koller J; Kässmann H; Galvan G
J Nucl Med; 1998 May; 39(5):798-802. PubMed ID: 9591578
[TBL] [Abstract][Full Text] [Related]
14. [Phase 2 clinical study of 123I-N-(2-diethylaminoethyl)-2-iodobenzamide in the diagnostic of primary and metastatic ocular melanoma].
Sillaire-Houtmann I; Bonafous J; Veyre A; Mestas D; D'Incan M; Moins N; Kemeny JL; Chossat F; Bacin F
J Fr Ophtalmol; 2004 Jan; 27(1):34-9. PubMed ID: 14968075
[TBL] [Abstract][Full Text] [Related]
15. Radiopharmaceutical therapy of patients with metastasized melanoma with the melanin-binding benzamide 131I-BA52.
Mier W; Kratochwil C; Hassel JC; Giesel FL; Beijer B; Babich JW; Friebe M; Eisenhut M; Enk A; Haberkorn U
J Nucl Med; 2014 Jan; 55(1):9-14. PubMed ID: 24277756
[TBL] [Abstract][Full Text] [Related]
16. Radioiodine-labelled alpha-methyl-tyrosine in malignant melanoma: cell culture studies and results in patients.
Böni R; Steinert H; Huch Böni R; Von Schulthess GK; Meyer J; Dummer R; Burg G; Westera G
Br J Dermatol; 1997 Jul; 137(1):96-100. PubMed ID: 9274632
[TBL] [Abstract][Full Text] [Related]
17. A radiolabelled iodobenzamide for malignant melanoma staging.
Rodot S; Darcourt J; Bussière F; Lacour JP; Migneco O; Thyss A; Michelot JM; Bonafous JF; Schneider M; Barety M
Melanoma Res; 1994 Oct; 4(5):307-12. PubMed ID: 7858415
[TBL] [Abstract][Full Text] [Related]
18. 123I-N-(2-diethylaminoethyl)-2-iodobenzamide: a potential imaging agent for cutaneous melanoma staging.
Moins N; D'Incan M; Bonafous J; Bacin F; Labarre P; Moreau MF; Mestas D; Noirault E; Chossat F; Berthommier E; Papon J; Bayle M; Souteyrand P; Madelmont JC; Veyre A
Eur J Nucl Med Mol Imaging; 2002 Nov; 29(11):1478-84. PubMed ID: 12397467
[TBL] [Abstract][Full Text] [Related]
19. Dosimetry of a D2/D3 dopamine receptor antagonist that can be used with PET or SPECT.
Mozley PD; Stubbs JB; Kim HJ; McElgin W; Chumpradit S; Kung MP; Romaniello G; Kung HF
J Nucl Med; 1995 Jul; 36(7):1322-31. PubMed ID: 7790963
[TBL] [Abstract][Full Text] [Related]
20. Detection of melanoma lesions using ¹³¹I-IMBA obtained by electrophilic substitution of ¹³¹I for metal organic substituent - a preliminary communication.
Janczak M; Nejc D; Bieńkiewicz M; Płachcińska A; Kuśmierek J
Nucl Med Rev Cent East Eur; 2010; 13(2):70-5. PubMed ID: 21598230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
